Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of LNK01004 Ointment in Adults With Atopic Dermatitis. [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating the safety, tolerability, and pharmacokinetics of LNK01004 ointment in adults with atopic dermatitis; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• LNK01004 ointment

Snippet

Sponsor: Lynk Pharmaceuticals Co., Ltd | Conditions: Atopic Dermatitis | Phase 1 | Status: COMPLETED